Intercept Pharmaceuticals, Inc. Logo

Press releases

Date Title and Summary View
Toggle Summary Intercept Pharmaceuticals Expands Senior Management
Company establishes New COO Position, Announces Chief Medical Officer and Vice President, Program Management
View HTML
Toggle Summary Intercept Pharmaceuticals Closes $41 Million Equity Financing
Company Announces Lead Compound INT-747 Appears Well Tolerated in Phase 1 Study
View HTML
Toggle Summary Intercept Pharmaceuticals Announces Closing Of New Financing Round
Company to Present at Rodman & Renshaw Global Healthcare Conference
View HTML
Toggle Summary Liver And Metabolic Disease Company Intercept Pharmaceuticals To Present At Rodman & Renshaw Healthcare Conference
Company Also to Present Two Studies at The Liver Meeting™ Supporting Rationale
View HTML
Toggle Summary Intercept Pharmaceuticals Announces Publication Of Study Demonstrating Its Lead Compound Can Reverse Liver Fibrosis View HTML